Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
The presence of mild hyperoxaluria in recurrent calcium oxalate stone formers is controversial. The aim of this study was to identify recurrent stone formers with mild hyperoxaluria and to classify them further by assessing their response to a low oxalate diet. In addition, the prevalence of other risk factors for stone formation in this group of patients was investigated. A total of 207 consecutive patients with recurrent renal calculi were screened and 40 (19%) were found to have mild hyperoxaluria. Of these, 18 (45%) responded to dietary oxalate restriction by normalising their urinary oxalate. The remaining 22 patients were classified as having idiopathic hyperoxaluria and were subdivided into those in whom urinary oxalate excretion was consistently elevated in all specimens measured and those in whom the elevation was intermittent in nature. Dietary oxalate restriction had a partially beneficial effect in lowering oxalate excretion in the patients with persistent hyperoxaluria. No difference in urinary oxalate excretion was found after dietary restriction in the patients with intermittent hyperoxaluria. Other risk factors, including dietary, absorptive and renal hypercalciuria and hypocitraturia, were documented, the prevalence of which (65%) was not significantly different from that (62.5%) found in 40 age- and sex-matched calcium stone formers without hyperoxaluria. The prevalence of hyperuricosuria was significantly greater in patients with hyperoxaluria when compared with stone controls. Further studies are required to elucidate the underlying mechanisms of hyperoxaluria in recurrent stone formers.
Laminski
N A
NA
Metabolic Stone Clinic, Johannesburg Hospital, South Africa.
Meyers
A M
AM
Kruger
M
M
Sonnekus
M I
MI
Margolius
L P
LP
D002118:Calcium / Q000378:metabolism; D002129:Calcium Oxalate / Q000032:analysis; D002130:Calcium Phosphates / Q000032:analysis; D048909:Diabetes Complications; D004032:Diet / Q000009:adverse effects*; D006801:Humans; D006959:Hyperoxaluria / Q000150:complications* / Q000178:diet therapy / Q000378:metabolism; D007669:Kidney Calculi / Q000737:chemistry / Q000150:complications* / Q000178:diet therapy / Q000378:metabolism; D010070:Oxalates / Q000378:metabolism; D012008:Recurrence; D012307:Risk Factors
D002130:Calcium Phosphates; D010070:Oxalates; D002129:Calcium Oxalate; D002118:Calcium